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Nowadays, the concept of Quality by Design and Design Space (DS) have become 
widespread in the field of pharmaceutical and analytical science. In the framework of method 
development, the DS computation can be carried out using design of experiment approach 
(DoE). The combination of these methodologies (DoE-DS) are applied to optimize the 
operating conditions governing a separation and to estimate the robustness of the developed 
method, simultaneously. 
1.1. What is the Design Space?
ICH Q8(R2) guideline provides a harmonized guidance to improve the robustness and 
reliability of pharmaceutical development. In this guideline, DS is defined as “the 
multidimensional combination and interaction of input variables (e.g. material attributes) and 
process parameters that have been demonstrated to provide assurance of quality“. In the 
method development framework, the DS defines a space wherein the separation is 
complete taking into account the uncertainty in models, measurements and process.
This guideline follows with “working within the design space is not considered as a change”. 
Therefore, the DS can be considered as a zone of theoretical robustness as the method 
parameters modifications do not result in significant variations in terms of separation 
quality.
1.2. How to compute the Design Space?
First, DoE are used to model the retention factors against some chromatographic factor (e.g. 
pH, gradient time, temperature, etc.). The beginning, the apex and the end of each peak (i.e. 
respectively, tB, tR and tE) are individually modelled by multiple linear regressions.
Second, a criterion is selected to quantify the quality 
of a separation. The chromatographic resolution (RS) 
is generally used to do it. But, the division taking 
place in its calculation leads to inaccurate estimation 
of the error that affects this latter. Thus, a simpler 
criterion is introduced, the separation criterion, S, as 
shown on Fig. 1. S is computed from the modelled 
retention times and prediction can be made over the 
experimental domain (i.e. for each experimental 
conditions within the workspace).
Third, the error affecting the modelled responses is 
propagated to S using Monte Carlo method. This 
step is very important as it significantly improves the 
prediction confidence. The DS can then easily be 
computed as the space where the separation is 
complete (S>0 min) and where the error is relatively 
low (P(S>0) is high) as shown by Eq. 1.
Fig. 1: Calculation of S for the critical pair
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Where x0 is a point in the experimental domain, χ. λ is the threshold on this criterion, π is the 
selected probability of acceptance. Symbols P and E respectively correspond to probability 
and mathematical expectation.
Thus, the robustness is evaluated by the quality criteria (π) and the DS shape. A high π and 
a large DS size means that the method is robust.
2. Results
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2.1. Pharmaceutical formulation. The first example is the optimization of the 
separation of a common cold pharmaceutical formulation containing phenylephrine, 
chlorpheniramine maleate, paracetamol, E110 (sunset yellow) and PVP-K30. A full factorial 
design was used to model the retention times against the pH and the gradient time.
Table 1: Full factorial design
Fig. 2: (a) Predicted versus experimental values for tR, tE and tB. (b) Corresponding residuals plots.
As depicted on Fig 2, 
the adequacy betw-
een the experimental 
retention times and 
the predicted one is 




buted between -0.2 
and 0.2 min.
Fig. 3: (a) Probability surface for the separation criterion (acceptance limit λ=0.1 min) optimum 
n°1 is depicted by the black circle (pH 4.3 – TG=28.0 min). (b) Magnification of the upper left 
zone, optimum n°2 is depicted by the black circle ( pH 10 – TG=10 min).
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Fig. 4: (a) Chromatogram 
recorded at optimum n°1 
(pH 4.3 – TG=28.0 min). (b) Chromatogram 
recorded at optimum n°2 






5=sunset yellow FCF, 
6= chlorpheniramine, 
7=PVP-K30.
2.2. Test sample. The second example is the optimization of the separation of a 
system suitability test mixture. The same full factorial design (see Table 1) was used.
As depicted on Fig 5, 
the adequacy betw-
een the experimental 
retention times and 
the predicted one is 





between -0.4 and 0.4 
min.
Fig. 5: (a) Predicted versus experimental values for tR, tE and tB. (b) Corresponding residuals plots.
DS
Fig. 6: (a) depicts the probability surface to obtain a separation (S) of at least 0 min The quality 
level is set to 85%. (b) predicted chromatogram at pH 3.0 and with TG = 30 min. (c) 
chromatogram recorded at this operating condition. 
This DoE-DS methodology was also successfully applied on a cannabinoids mixture [B. De 
Backer et al., J. Chrom. B 877 (2009) 4115], on the separation of sulindac and its related 
impurities [F. Krier et al., Drug Analysis 2010 poster], on the separation of 18 antimalarial
drugs [R.D. Marini et al., Drug Analysis 2010 poster] on extracts of spirospermum
penduliforum [M. Rafamantanana et al., Drug Analysis 2010 poster] and on extracts of 
strychnos usambarensis [I. Nistor et al., Drug Analysis 2010 oral communication]
Even if the number of experiments needed (n) might seem high regarding to conventional 
optimization approaches, the DoE-DS methodology is able to simultaneously model the 
chromatographic behaviour of each compound and provides optimal conditions in which the 
prediction error was analyzed in order to evaluate the method robustness.










Peaks labels and numbering
This design leads to 
17 experiments. (n = 
15+2 independent 
repetitions at the 
centre)
